1887
Volume 2007, Issue 1
  • ISSN: 0253-8253
  • E-ISSN: 2227-0426

ملخص

Records of patients attending the Andrology Clinic, Hamad Medical Corporation, Qatar; over a period often years were analyzed to determine the demographic features, contributory risk factors, and best methods of treatment for erectile dysfunction (ED). Of1,245patients with ages ranging from 19-78 years (mean 49 years) 45% were Qataris. Most complained of weak erections, a few reported ejaculatory dysfunction. Diabetes mellitus was the most frequent risk factor (53%) followed by hypertension (28%), smoking (27%) and coronary artery disease (14%). Oral Sildenafil given to 310 patients gave overall satisfaction to 75 (49%) of the 152 patients in whom satisfaction could be assessed; intracorporal injection given to 413 patients resulted in overall satisfaction to 107 (68%) of 157 in whom satisfaction could be assessed; penile prosthesis implantation in 64 patients remained an effective therapeutic modality with 31 (84%) of the 37 patients in whom satisfaction could be assessed being satisfied with the results.

Conclusion: Erectile dysfunction is as common in Qatar as it is in the rest of the world. The higher incidence of diabetes mellitus in the ED. population in the region forms the major risk factor and might reflect the need for the implementation of preventive strategies.

Loading

جارٍ تحميل قياسات المقالة...

/content/journals/10.5339/qmj.2007.1.10
٢٠٠٧-٠٦-٠١
٢٠٢٤-٠٧-٢٧
Loading full text...

Full text loading...

References

  1. Abdulbari B. Annual Statistical Report (2002) for health services provided in Qatar. Report from Ministry of Public Health & Hamad Medical Corporation. 2003;:117.
    [Google الباحث العلمي]
  2. Hermann M, Berger P. Hormonal changes in aging men: A therapeutic indication? Exp Gerontol. 2001; 36::1075.
    [Google الباحث العلمي]
  3. Schulman CC. The aging male: a challenge for urologists. Curr Opin Urol. 2000; 10::337.
    [Google الباحث العلمي]
  4. Seyam RM, Albakry A, Ghobish A, Arif H, Dandash K, Rashwan H. Prevalence of erectile dysfunction and its correlates in Egypt: A community-based study. Int J Impot Res. 2003; 15::237.
    [Google الباحث العلمي]
  5. Safarinejad MR. Prevalence and risk factors for erectile dysfunction in a population-based study in Iran. Int J Impot Res. 2003; 15::246.
    [Google الباحث العلمي]
  6. Dunn KM, Croft PR, Hackett GI. Sexual problems: A study of the prevalence and need for health care in the general population. Fam Pract. 1998; 15::519.
    [Google الباحث العلمي]
  7. Rosen RC. Prevalence and risk factors of sexual dysfunction in men and women. Curr Psychiatry Rep. 2000; 2::189.
    [Google الباحث العلمي]
  8. Verma KK, Khaitan BK, Singh OP. The frequency of sexual dysfunctions in patients attending a sex therapy clinic in north India. Arch Sex Behav. 1998; 27::309.
    [Google الباحث العلمي]
  9. Virag R, Beck-Ardilly L. Nosology, epidemiology, clinical quantification of erectile dysfunctions. Rev Med Interne. 1997; 18:Suppl 1:10.
    [Google الباحث العلمي]
  10. Dorey G. Is smoking a cause of erectile dysfunction? A literature review. Br J Nurs. 2001; 10::455.
    [Google الباحث العلمي]
  11. Al Helali NS, Abolfotouh MA, Ghanem HM. Pattern of erectile dysfunction in Jeddah city. Saudi Med J. 2001; 22::34.
    [Google الباحث العلمي]
  12. Bortolotti A, Fedele D, Chatenoud L, Colli E, Coscelli C, Landoni M, Lavezzari M, Santeusanio F, Parazzini F. Cigarette smoking: a risk factor for erectile dysfunction in diabetics. Eur Urol. 2001; 40::392.
    [Google الباحث العلمي]
  13. Braun M, Sommer F, Lehmacher W, Raible A, Bondarenko B, Engelmann U. [Erectile dysfunction]. Dtsch Med Wochenschr. 2004; 129::131.
    [Google الباحث العلمي]
  14. Sanchez de la Vega J, Amaya Gutierrez J, Alonso Flores JJ, Garcia Perez M. Erectile dysfunction in those under 40. Etiological and contributing factors. Arch Esp Urol. 2003; 56::161.
    [Google الباحث العلمي]
  15. Roth A, Kalter-Leibovici O, Kerbis Y, Tenenbaum-Koren E, Chen J, Sobol T, Raz I. Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1,412 Israeli men. Clin Cardiol. 2003; 26::25.
    [Google الباحث العلمي]
  16. Margolis SACT, Dunn EV, Reed RL. The health status of community based elderly in the United Arab Emirates. Arch Gerontol Geriatr. 2003; 37::1.
    [Google الباحث العلمي]
  17. Nehra A. Treatment of endocrinologic male sexual dysfunction. Mayo Clin Proc. 2000; 75::S40.
    [Google الباحث العلمي]
  18. Bodie J, Lewis J, Schow D, Monga M. Laboratory evaluations of erectile dysfunction: an evidence based approach. J Urol. 2003; 169::2262.
    [Google الباحث العلمي]
  19. Earle CM, Stuckey BG. Biochemical screening in the assessment of erectile dysfunction: what tests decide future therapy? Urology. 2003; 62::727.
    [Google الباحث العلمي]
  20. De la Torre Holguera P, Hernandez J, over D, Marti Malet J, Ochoteco Garcia J I. Assessment of erectile dysfunction with Doppler-duplex ultrasonography. Arch Esp Urol. 2001; 54::617.
    [Google الباحث العلمي]
  21. Abdel-Hamid IA, Eraky I, Fouda MA, Mansour OE. Role of penile vascular insufficiency in erectile dysfunction in renal transplant recipients. Int J Impot Res. 2002; 14::32.
    [Google الباحث العلمي]
  22. Gresser U, Gleiter CH. Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil—review of the literature. Eur J Med Res. 2002; 7::435.
    [Google الباحث العلمي]
  23. Tsujimura A, Yamanaka M, Takahashi T, Miura H, Nishimura K, Koga M, Iwasa A, Takeyama M, Matsumiya K, Takahara S, Okuyama A. The clinical studies of sildenafil for the ageing male. Int J Androl. 2002; 25::28.
    [Google الباحث العلمي]
  24. Amar E, Kobelinsky M, Khoury R, Sarkis P, Bouyer I, Dauphin A, Delmas V, Boccon-Gibod L. Treatment of sexual impotency by intra-cavernous injections of prostaglandin El. Report of 180 patients. Prog Urol. 1993; 3::971.
    [Google الباحث العلمي]
  25. Tan HL. Economic cost of male erectile dysfunction using a decision analytic model: for a hypothetical managed-care plan of 100,000 members. Pharmacoeconomics. 2000; 17::77.
    [Google الباحث العلمي]
/content/journals/10.5339/qmj.2007.1.10
Loading
  • نوع المستند: Research Article
الموضوعات الرئيسية demographic patternErectile dysfunction and prevalence of risk factors

الأكثر اقتباسًا لهذا الشهر Most Cited RSS feed

هذه الخانة مطلوبة
يُرجى إدخال عنوان بريد إلكتروني صالح
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error